Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zamboni

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Internal Medicine Journal|February 17, 2015
Efficacy of non-invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH < 7.35: a feasibility pilot studyS Fiorino, L Bacchi-Reggiani, E Detotto, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2011
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancerWilliam C Zamboni, Austin J Combest, Julie A DeLoia, et al.
Journal of Clinical Pharmacology|January 15, 2011
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.
Journal of Liposome Research|June 10, 2010
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor modelsWilliam C Zamboni, Julie L Eiseman, Sandra Strychor, et al.
International Journal of Nanomedicine|November 1, 2012
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patientsHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.
Blood Advances|February 28, 2025
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemiaFarhad Ravandi, Sravanti Rangaraju, Hagop Kantarjian, et al.
Journal of Liposome Research|July 15, 2010
Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumorsWilliam C Zamboni, Lauren J Maruca, Sandra Strychor, et al.
European Journal of Clinical Pharmacology|August 31, 2013
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumorsHuali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
International Journal of Nanomedicine|February 25, 2015
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumorsHuali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
European Radiology|August 20, 2022
Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic-a survey of the European Society of Oncologic Imaging (ESOI)Nathania Bonanno, Dania Cioni, Damiano Caruso, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Internal Medicine Journal|February 17, 2015
Efficacy of non-invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH < 7.35: a feasibility pilot studyS Fiorino, L Bacchi-Reggiani, E Detotto, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2011
Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal cancerWilliam C Zamboni, Austin J Combest, Julie A DeLoia, et al.
Journal of Clinical Pharmacology|January 15, 2011
Population pharmacokinetics of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.
Journal of Liposome Research|June 10, 2010
Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor modelsWilliam C Zamboni, Julie L Eiseman, Sandra Strychor, et al.
International Journal of Nanomedicine|November 1, 2012
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patientsHuali Wu, Ramesh K Ramanathan, Beth A Zamboni, et al.
Blood Advances|February 28, 2025
A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemiaFarhad Ravandi, Sravanti Rangaraju, Hagop Kantarjian, et al.
Journal of Liposome Research|July 15, 2010
Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumorsWilliam C Zamboni, Lauren J Maruca, Sandra Strychor, et al.
European Journal of Clinical Pharmacology|August 31, 2013
Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumorsHuali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
International Journal of Nanomedicine|February 25, 2015
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumorsHuali Wu, Jeffrey R Infante, Vicki L Keedy, et al.
European Radiology|August 20, 2022
Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic-a survey of the European Society of Oncologic Imaging (ESOI)Nathania Bonanno, Dania Cioni, Damiano Caruso, et al.
Pageof 19